Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced results for the first quarter ended March 31, 2013. Revenue for the first quarter was $34.5 million, an increase of $2.1 million, or 6%, as compared to the first quarter of 2012. The year-over-year revenue increase consisted primarily of $1.5 million from sales of VASER systems and $2.1 million from sales of treatment tips and other consumables, partially offset by a decline in sales of Liposonix systems in North America.
Help employers find you! Check out all the jobs and post your resume.
